1.
The over-all 3-and 5-year disease free actuarial survival rates were 42% and 33%.
3、5年生存率为40％和33％。
2.
The five-year survival rate (SR),disease free survival rate (DFSR) were 65 6% and 54 5%,respectively.
总的5年生存率、无瘤生存率分别为65．6％和54．5％。
3.
The 1, 3 and 5-year sur-vival rate were 40.8%.
全组1、3、5年生存率分别为40.80％、16.11％、11.39％;
4.
Results Symptom relief rate was 90%. The overall actuarial 5year survival rate was 23.0±7.5% .
结果症状缓解率达90％左右，5年生存率23．0±7．5％。
5.
The6- month,2- year, and5- year patient survival were similar between the two groups.
两组病人的6个月、年和5年生存率无明显差异。
6.
Results The overall 5 year survival rate was 55.1%.
结果全组鼻腔鳞癌患者的5年生存率为55.1%。
7.
The 5-year survival rate of benign PRT was 89.29%, the 5-year survival rate of malignant PRT was 20.80%.
良、恶性肿瘤5年生存率分别为89·29%和20·80%。
8.
Evaluation of 5-year Survival Rate and Survival Factors in Post-operative Patients with Non-small Cell Lung Cancer;
影响非小细胞肺癌患者术后5年生存率及生存因素分析
9.
Comparison and Analysis of 5-year Survival Rate between Stapling Device Application on Sphincter-saving Operation and Miles Operation in the Treatment of Low Rectal Carcinoma;
低位直肠癌应用吻合器保肛手术与Miles手术5年生存率比较分析
10.
Two recent studies using large numbers of cancer patients found the five-year survival rate for patients using Iscador was no better than for the control group.
最近对大量癌症病人的研究发现，服用Iscador的病人的5年生存率并不比对照组高。
11.
The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively.
全组5年总生存率和无病生存率分别为89%和73%。
12.
The DFS and probability of relapse at 5 years were 6 7.8%and 16.8%respectively for all patients.
全组患者5年无病生存率及复发率分别为67．8％及16．8％。
13.
Analysis of Risk Factors for Overall Survival at 5 Years in 96 Patients after Allogeneic Hematopoietic Cell Transplantation
96例异基因造血干细胞移植后5年总生存率的危险因素分析
14.
Median age was 17 years (range, 7-63 years).
5年存活率也从37.5%增加至63.6%。
15.
The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively.
3年总生存率和无病生存率分别为66．3％和59．5％。
16.
10-year survival rate and 10-year NED rate were 62.4% and 60.2%.
10年生存率、健在率分别为62.4%及60.2%。
17.
The interest rate for the savings account 4.5%.
储蓄存款的利率是4。5％。
18.
The 3-years survival rates of the patients treated with IAD by flutamide and cascodex were(72.7%) and 80.0% respectively. The overall 3 years survival rates of IAD was 76.2%.
甲组3年生存率为72.7%,乙组为80.0%,总3年生存率为76.2%。